ThermoGenesis 

$0.000100
13
+$0.00+0% Friday 14:57

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.0001
52W Low
0.0001
Volume
100
Avg. Volume
304
Mkt Cap
795.3
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

22NovExpected
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q1 2024
Q2 2024
Q3 2024
-3.31
-2.2
-1.09
0.02
Expected EPS
0.02
Actual EPS
N/A

Financials

-190.31%Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
18.89MRevenue
-35.95MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow THMO. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Baxter International
BAX
Mkt Cap10.77B
Baxter International Inc. competes in the medical devices and bioscience field, offering products that overlap with ThermoGenesis' cell processing and blood management solutions.
Thermo Fisher Scientific
TMO
Mkt Cap174.42B
Thermo Fisher Scientific Inc. provides a broad range of laboratory equipment and services, including cell therapy technologies, directly competing with ThermoGenesis' offerings.
Becton Dickinson
BDX
Mkt Cap40.3B
Becton, Dickinson and Company offers a variety of medical devices and laboratory equipment, competing in the cell processing space similar to ThermoGenesis.
Danaher
DHR
Mkt Cap127.47B
Danaher Corporation operates in the life sciences and diagnostics sectors, offering products and services that compete with ThermoGenesis' cell-based technologies.
Bio-Rad Laboratories
BIO
Mkt Cap7.65B
Bio-Rad Laboratories, Inc. provides instruments and consumables in the field of life science research and clinical diagnostics, competing with ThermoGenesis in the biotechnology product space.
Illumina
ILMN
Mkt Cap24.35B
Illumina, Inc. specializes in genomics and DNA sequencing technologies, which can be seen as complementary or competitive to ThermoGenesis' work in cell processing and therapy.
Qiagen NV
QGEN
Mkt Cap7.64B
Qiagen N.V. offers sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the genomic and molecular space with ThermoGenesis.
Agenus
AGEN
Mkt Cap137.42M
Agenus Inc. focuses on immunotherapy including cell therapies, which competes with ThermoGenesis' efforts in cell-based treatment technologies.
Novartis
NVS
Mkt Cap292.07B
Novartis AG, through its advanced therapy platforms, competes in the cell therapy and regenerative medicine space, overlapping with ThermoGenesis' market.
Pfizer
PFE
Mkt Cap149.38B
Pfizer Inc. is involved in biopharmaceuticals, including efforts in gene therapy and cell therapy, areas where ThermoGenesis also operates.

About

ThermoGenesis Holdings, Inc., founded in 1986 and based in Rancho Cordova, California, is a global innovator specializing in automated systems for cell-banking, cell-processing, and cell-based therapeutic applications. The company's advanced solutions are available across the United States, China, the United Arab Emirates, Vietnam, and other international regions. Its product portfolio encompasses medical devices crucial for automated cell processing. For clinical bio-banking purposes, ThermoGenesis provides the AXP II Automated Cell Separation System, a fully closed system designed for isolating stem and progenitor cells from umbilical cord blood. Complementing this is the BioArchive Automated Cryopreservation System, a robotic, liquid nitrogen-controlled system for both freezing and long-term cryogenic storage of cord blood samples and cell therapeutic products used in clinical environments. In the realm of point-of-care applications, the company offers the XP Point-of-Care System, an automated, sterile, and closed platform that facilitates the rapid processing of autologous stem cells derived from peripheral blood or bone marrow aspirate directly within clinical settings such as surgical centers. Additionally, the PXP-1000 System is another automated, closed solution, engineered for fast and reproducible separation of multiple cellular components from blood with minimal red blood cell contamination. For general laboratory use, ThermoGenesis provides its X-Series cell processing products, including X-Lab for cell isolation, the X-Wash System for efficient cell washing and reformulation, and X-Mini for high-efficiency, small-scale cell purification. Beyond its product offerings, the company also delivers contract development and manufacturing (CDMO) services specifically for cell and cell-based gene therapies. Its medical device products are marketed and sold through a network of independent distributors, as well as directly to end-user customers. The company, formerly known as Cesca Therapeutics Inc., officially adopted the name ThermoGenesis Holdings, Inc. in November 2019.
Show more...
CEO
Dr. Xiaochun Xu M.B.A., Ph.D.
Employees
25
Country
United States
ISIN
US88362L2097

Listings

0 Comments

Share your thoughts

FAQ

What is ThermoGenesis stock price today?
The current price of THMO is $0.00 USD — it has increased by +0% in the past 24 hours. Watch ThermoGenesis stock price performance more closely on the chart.
What is ThermoGenesis stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange ThermoGenesis stocks are traded under the ticker THMO.
Is ThermoGenesis stock price growing?
THMO stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year ThermoGenesis has showed a +0% increase.
What is ThermoGenesis market cap?
Today ThermoGenesis has the market capitalization of 795.3
What is ThermoGenesis revenue for the last year?
ThermoGenesis revenue for the last year amounts to 18.89M USD.
What is ThermoGenesis net income for the last year?
THMO net income for the last year is -35.95M USD.
How many employees does ThermoGenesis have?
As of June 15, 2026, the company has 25 employees.
In which sector is ThermoGenesis located?
ThermoGenesis operates in the Health & Wellness sector.
When did ThermoGenesis complete a stock split?
The last stock split for ThermoGenesis was on December 22, 2022 with a ratio of 1:45.
Where is ThermoGenesis headquartered?
ThermoGenesis is headquartered in Rancho Cordova, United States.